The purpose of this study is to evaluate the safety, tolerability and efficacy of 3 doses of GRT6005 taken once daily for 4 weeks in outpatients with moderate-to-severe painful osteoarthritis of the knee.
The purpose of the trial is to determine whether GRT6005 is effective in patients with pain due to osteoarthritis of the knee.